Christopher F. O'Brien
2014
In 2014, Christopher F. O'Brien earned a total compensation of $3.7M as Chief Medical Officer at Neurocrine Biosciences.
Compensation breakdown
| Bonus | $275,400 |
|---|---|
| Option Awards | $1,183,360 |
| Salary | $459,000 |
| Stock Awards | $1,743,510 |
| Other | $24,818 |
| Total | $3,686,088 |
O'Brien received $1.7M in stock awards, accounting for 47% of the total pay in 2014.
O'Brien also received $275.4K in bonus, $1.2M in option awards, $459K in salary and $24.8K in other compensation.
Rankings
In 2014, Christopher F. O'Brien's compensation ranked 2,363rd out of 13,032 executives tracked by ExecPay. In other words, O'Brien earned more than 81.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,363 out of 13,032 | 82nd |
Division Manufacturing | 844 out of 4,965 | 83rd |
Major group Chemicals And Allied Products | 259 out of 1,690 | 85th |
Industry group Drugs | 200 out of 1,369 | 85th |
Industry Biological Products, Except Diagnostic Substances | 32 out of 241 | 87th |
Source: SEC filing on April 20, 2017.
O'Brien's colleagues
We found three more compensation records of executives who worked with Christopher F. O'Brien at Neurocrine Biosciences in 2014.